Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Medtronic
Express Scripts
McKesson
Moodys

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR LATANOPROSTENE BUNOD


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Latanoprostene Bunod

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01895972 ↗ Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT Completed Bausch & Lomb Incorporated Phase 3 2013-07-05 The objective of this study is to demonstrate the clinical safety of latanoprostene bunod 0.024% once daily (QD) over a 1-year treatment period.
NCT01895985 ↗ Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers Completed Bausch & Lomb Incorporated Phase 1 2013-07-01 The objective of this study is to evaluate the effect of latanoprostene bunod dosed once daily (QD) in reducing intraocular pressure (IOP) measured over a 24-hour period in healthy subjects.
NCT03931317 ↗ Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity Completed Bausch & Lomb Incorporated N/A 2018-12-03 The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
NCT03931317 ↗ Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity Completed University of California, San Diego N/A 2018-12-03 The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
NCT03949244 ↗ Nailfold Capillary Blood Flow With Latanoprost Bunod Completed Icahn School of Medicine at Mount Sinai Phase 4 2019-08-15 The purpose of this study is to look at the relationship of small blood vessels irregularities observed with an imaging system called video nailfold capillaroscopy in people with primary open-angle glaucoma. Nailfold capillaroscopy (NFC) is a video camera with a magnifying lens used for studying the movement of blood in small blood vessels. It is simple, safe and does not penetrate the skin. The skin fold that is at the tip of the finger is called the "nailfold". NFC has been used to assess blood vessel narrowing in patients with glaucoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Latanoprostene Bunod

Condition Name

Condition Name for Latanoprostene Bunod
Intervention Trials
Ocular Hypertension 2
Glaucoma, Open-Angle 1
Intraocular Pressure 1
Normal Tension Glaucoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Latanoprostene Bunod
Intervention Trials
Ocular Hypertension 3
Hypertension 3
Glaucoma, Open-Angle 3
Glaucoma 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Latanoprostene Bunod

Trials by Country

Trials by Country for Latanoprostene Bunod
Location Trials
United States 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Latanoprostene Bunod
Location Trials
New York 2
New Jersey 2
Minnesota 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Latanoprostene Bunod

Clinical Trial Phase

Clinical Trial Phase for Latanoprostene Bunod
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 1 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Latanoprostene Bunod
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Latanoprostene Bunod

Sponsor Name

Sponsor Name for Latanoprostene Bunod
Sponsor Trials
Bausch & Lomb Incorporated 4
University of California, San Diego 1
Icahn School of Medicine at Mount Sinai 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Latanoprostene Bunod
Sponsor Trials
Industry 4
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
AstraZeneca
McKesson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.